|
11 Dec 2008 |
AFFiRiS Begins Development of a Parkinson's Vaccine
|
|
09 Dec 2008 |
Diamyd(R) Diabetes Vaccine to be Used in Prevention Study
|
|
09 Dec 2008 |
SARS Vaccine Achieves Neutralizing Responses in First U.S. Human Trial
|
|
09 Dec 2008 |
Cytos Biotechnology starts phase IIb clinical study with CYT003-QbG10 monotherapy for the treatment of allergic diseases
|
|
03 Dec 2008 |
Geron Announces Initiation of Phase I Clinical Trial of Vaccine Candidate Targeting Telomerase by MERCK & Co., Inc.
|
|
03 Dec 2008 |
AVI BioPharma Files IND for Clinical Trial of Marburg Virus Treatment
|
|
03 Dec 2008 |
Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children
|
|
03 Dec 2008 |
Cell Genesys and Takeda Announce Termination of Collaboration Agreement for GVAX Immunotherapy for Prostate Cancer
|
|
02 Dec 2008 |
First-Ever Human Trial of DNA-Based Immunotherapy Delivered Using Inovio Biomedical's Electroporation Technology Shows Safety and Durable Systemic Clinical Response
|
|
02 Dec 2008 |
Protalix BioTherapeutics Announces Completion of Enrollment for its Pivotal Phase III Clinical Trial of Gaucher Disease
|
|
01 Dec 2008 |
GeoVax’s Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America
|
|
01 Dec 2008 |
Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial
|
|
20 Nov 2008 |
IDRI and Immune Design Corp. Enter License Agreement on GLA Vaccine Adjuvant
|
|
14 Nov 2008 |
New Data Points to Long Lasting Beneficial Effects of CEL-SCI's Rheumatoid Arthritis Vaccine
|
|
13 Nov 2008 |
GARDASIL(R), Merck's Cervical Cancer Vaccine, Demonstrated Efficacy in Preventing HPV-Related Disease in Males in Phase III Study
|
|
12 Nov 2008 |
Vical Completes Enrollment and Reports Positive Interim Data in CMV Vaccine Phase 2 Trial
|
|
05 Nov 2008 |
Bavarian Nordic reports successful safety data from Phase II study with IMVAMUNE (R)
|
|
04 Nov 2008 |
MedImmune Advances Pediatric Disease Prevention Program With Start of Phase 1/2a Clinical Trial for Respiratory Syncytial Virus Vaccine
|
|
03 Nov 2008 |
Canopus BioPharma Announces Positive Results in Human Study of Novel Peptide Cancer Vaccine
|
|
03 Nov 2008 |
NasVax Commences a Phase I/ IIa Dose-Optimization Clinical Study of VaxiSomeTM-Adjuvanted Influenza Vaccine
|
|
31 Oct 2008 |
Celldex Presents Results from Phase 1 Studies of CDX-1307 with GM-CSF
|
|
29 Oct 2008 |
Nabi Biopharmaceuticals Announces Successful Final Results of NicVAX(r) Immunogenicity Study
|
|
29 Oct 2008 |
Launch of a ph.III clinical trial in adults for Oralair Grasses in the US
|
|
27 Oct 2008 |
High-Dose Influenza Vaccine Shows Increased Immune Response Among Adults 65 Years of Age and Older
|
|
27 Oct 2008 |
Phase 3 Data Indicate Investigational 13-valent Vaccine May Broaden Protection Against Pneumoccocal Disease in Children Younger than Two
|
